Next, we identified the direct target of this microRNA, Bace1. Further research to address the roles of non-coding RNAs in specific hypothalamic populations and identify the target(s) of miR-15a and other microRNAs might pave the way towards developing novel metabolic disorders-targeting therapeutics. Here, BACE1 is linked to metabolic disease.